WebAug 20, 2016 · 新辅助治疗资料.pptx,2012 SABCS 重要研究选粹 ---- 新辅助治疗 目录 新辅助乳腺癌协作研究(CTNeoBC)的荟萃分析结果 接受新辅助化疗的淋巴结阳性(T0-T4, N1-2)乳腺癌前哨淋巴结手术的作用 新辅助化疗治疗非常年轻的乳腺癌患者 治疗前中心活检Ki67水平是GeparTrio新辅助研究中的预测和预后因素 新辅助乳腺癌 ... WebPathological complete response (pCR) following chemotherapy is strongly associated with both breast cancer subtype and long-term survival. Within a phase III neoadjuvant chemotherapy trial, we sought to determine whether the prognostic implications of pCR, TP53 status and treatment arm (taxane versus non-taxane) differed between intrinsic …
Pathological complete response and long-term …
WebFeb 14, 2014 · Here, we present initial results from the CTNeoBC pooled analysis. Methods Search strategy and selection criteria We searched PubMed, Embase, and Medline for … WebDive into the research topics of 'Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis'. Together they form a unique fingerprint. Progression-Free Survival Medicine & Life Sciences 100% ceiling joist span charts per 2018 ibc
Carboplatin for Patients With Triple-Negative Breast Cancer
WebFeb 14, 2014 · This article has been corrected. See Lancet. 2024 Mar 9;393(10175):986. A comment on this article appears in "Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open Question." JAMA Oncol. 2024 Mar 1;3(3):416. A comment on this article appears in … WebFindings: Trial-level data from CTNeoBC were used as the training data set to derive an empirical nonlinear model for predicting long-term outcomes based on pCR results. A Cox regression model was used to evaluate the relationship among treatments, event hazards, and pCR as joint covariates. ceiling joist span chart spf